41

MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER [email protected]

Embed Size (px)

Citation preview

Page 1: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov
Page 2: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

MARIE CSETE MD, PhDCHIEF SCIENTIFIC OFFICER

[email protected]

Page 3: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

CANCER SURVIVAL

Early Development

DRUG DEVELOPMENT

TOXICICOLOGY

TRANSPLANTATIONDEGENERATIVE DISEASES

TRAUMA:Spinal cordBurnsHead injury

AGING

TISSUEENGINEERING

Page 4: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

ALL STEM CELLS

CAN EITHER

-SELF-RENEW

and/or

-GENERATE SEVERALKINDS OF CELL TYPES

Page 5: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

SELF-RENEWAL

Stem Stem

StemStem Stem

Stem Stem

X

XX

StemX

Page 6: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

BLOOD STEM CELLS ARE PLURIPOTENT

Page 7: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

“-POTENCY”

• Multipotent: A few

• Pluripotent: A lot

• Totipotent: Every kind of cell including cells of the body (somatic) and cells of the germline (eggs, sperm)

Page 8: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

TOTIPOTENT

• ONLY EMBRYONIC STEM CELLS ARE CONSIDERED TOTIPOTENT

• BUT REALLY THEY ARE NOT TOTIPOTENT BECAUSE OF THE ISSUES OF COMPLEX ORGANIZATION

• ONLY THE FERTILIZED EGG

IS REALLY TOTIPOTENT

Page 9: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

WHERE DO YOU GET THEM?

ADULT STEM CELLS

-ANY STAGE OF EMBRYO

-ANY STAGE OF ADULTHOOD

EMBRYONIC STEM CELLS

-BLASTOCYST EMBRYOS

-SCNT: Somatic cell nuclear transfer

-PARTHENOTES

-iPS: Induced pluripotent cells

Page 10: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin website

Page 11: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

Page 12: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

Page 13: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

Page 14: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

. University of Wisconsin, 2001.

Embryonic stem cells are derived from the inner cell mass of the blastocyst stage embryo

Page 15: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

In the lab, trophoblast is removed and the embryonic stem cells singly selected from the inner cell mass

Page 16: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

ES cell cultivation in the laboratory: easier with mouse than human cells

Page 17: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

University of Wisconsin, 2001.

Using a variety of tools, in theory any cell type can be made

Page 18: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov
Page 19: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

HUMAN EMBRYONIC STEM CELLS

.

Page 20: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

• Where they come from• Potency• Proliferative senesence (source material

abundance)

EMBRYONIC VS. ADULT STEM CELLS

Important differences:

Page 21: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

1997—DOLLY andTHE ERA OF CLONEDANIMALS

Page 22: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

+

Page 23: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

ADAPTED FROM WWW.NIH.GOV/NEWS/STEMCELL/FIG4B.GIF

Blastocyst

Inner Cell Mass(Pluripotent)

Egg Cell (Remove Nucleus)

(Fusion)

Somatic Cell Nuclear Transfer

(Extract Inner Cell Mass)

Cultured PluripotentEmbryonic Stem Cells

Somatic Cell Nuclear Transfer: IS NOT HUMAN CLONING

Somatic Cell nucleus (any cell in the body other than an egg or germ cell)

(Stimulate Cell Division Process)

ADAPTED FROM WWW.NIH.GOV/NEWS/STEMCELL/FIG3.GIF

Page 24: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Patient advocacy for SCNT

• No immunologic barrier with cells generated from recipient

• Screening drugs for many common diseases using clones from families with inherited diseases

• First glimpse into early development

• Does not require use of embryos

Page 25: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov
Page 26: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov
Page 27: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Use for parthenogenetic lines

• Genetic homozygosity

• Bank cells with specific MHC proteins

• Other uses? Engineer cells for HIV resistancemake HSC for marrow transplantation

• SCNT AND PARTHENOGENESIS REQUIRE AN EGG

• Human egg donation is not trivial

Page 28: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

All 3 germ layersrepresented-ectoderm-mesoderm-endoderm

Functional diffcell types

Page 29: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

How/why would this work?

• Huge interconnectedness of protein

networks

• Changes silencing status of whole genome: These factor awaken silenced genes all over the chromosomes

• Ultimate test of pluripotency: Make a whole organism

Page 30: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

iPS lines used to make mice

Reported simultaneouslyby 3 groups-Jaenisch (MIT)-Hochedlinger (Harvard)*-Yamanaka (Japan)

*20% of the 121 offspring developed tumors

-viral vectors?-not from vectors?

Page 31: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Hard problems

• What are network requirements for totipotency?

• Still left with little control over differentiation– Transcription and environment– Functional integration into tissue

• ES vs. cancer: Many overlapping traits

• Scale-up/manufacture: unsolved

Page 32: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Making ES cells easier than controlling them: MUSCLE

Page 33: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

?muscle fat

Positive and negative signals

redoxreduce oxidize

Page 34: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

CONTROL 2.

GUTSKINCARDIACMUSCLESKELETALMUSCLEPANCREATICBETACELLSHEPATOCYTESNEURONSSCHWANNCELLSASTROCYTESSMOOTHMUSCLEBONEPLATELETSREDCELLSWHITECELLSKUPFFERCELLSTENDON

Page 35: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Complex development

• Recapitulate the uterine environment and signals– Engineering interface critical

• Recapitulate the developmental course

ESdefinitive endodermforegut endodermpancreatic endoderminsulin producing mature beta cells

(Dr. Melissa Carpenter, NOVOCELL)

Page 36: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Growth cues to imitiate complex organization of embryos

Page 37: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Critical issues for translation

OLIGODENDROCYTES ASTROCYTES

?Transplant progenitorsrisk of astrocyte scarTransplant mature oligodendrocytesthey don’t survive transplant

Page 38: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Tumors and stem cells• Common traits: Undifferentiated, pluripotency, highly

proliferative, self-renewing, migration, common markers• Teratomas • Permissive environments • Cancer stem cells are those likely to escape treatment• Ultimately understanding stem cells will lead to

enormous gains in cancer biology• Chemotx wipes out stem cells?

Page 39: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov

Inner core: Slowly dividing neuroepithealial cells—Roy et al, Nature Med 2006

Page 40: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov
Page 41: MARIE CSETE MD, PhD CHIEF SCIENTIFIC OFFICER mcsete@cirm.ca.gov